Faster-acting insulin aspart vs insulin aspart as part of basal–bolus therapy improves postprandial glycaemic control in uncontrolled Type 2 diabetes in the double-blinded onset 2 trial
Abstract
Poster abstract A46 (P110) in the section Science in clinical practice 1 from the Diabetes UK Professional Conference 2017, Manchester Central, Manchester, 8–10 March 2017.
Citations
Altmetric:
Date
2017-03-08
Type
Conference Output
Subject
Diabetes
Citation
Saravanan P, Bowering K, Case C, Harvey J, Reeves M, Sampson M, Strzinek R, Bretler DM, Bang RB, Bode BW. Faster-acting insulin aspart vs insulin aspart as part of basal–bolus therapy improves postprandial glycaemic control in uncontrolled Type 2 diabetes in the double-blinded onset 2 trial. Diabetic Medicine. 2017 Mar;34(S1):21. doi: 10.1111/dme.8_13303.
Journal / Source Title
Diabetic Medicine
DOI
10.1111/dme.8_13303
PMID
Publisher
Wiley
Publisher’s URL
https://onlinelibrary.wiley.com/doi/10.1111/dme.8_13303#:~:text=A46%20(P110),onset%202%20trial